A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer. Walke P, Price JDW, Vizeacoumar FS, Joseph N, et al. Oncogene 2025 Apr 29. doi: 10.1038/s41388-025-03413.

Read + Share

Amedeo Smart

Independent Medical Education

Walke P, Price JDW, Vizeacoumar FS, Joseph N, et al. A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer. Oncogene 2025 Apr 29. doi: 10.1038/s41388-025-03413.
PMID: 40301542